These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22504334)

  • 1. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    García-Pagán JC; Gracia-Sancho J; Bosch J
    J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.
    Moeller M; Thonig A; Pohl S; Ripoll C; Zipprich A
    PLoS One; 2015; 10(3):e0121229. PubMed ID: 25793622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
    Wiest R; Groszmann RJ
    Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circulatory dysfunction syndrome associated with liver cirrhosis].
    Hartleb M
    Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
    Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
    Orrego Matte H
    Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiology of portal hypertension.
    Iwakiri Y
    Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preoperative evaluation of hemodynamics and the functional state of the liver in cirrhosis].
    Anisimova SM
    Vestn Khir Im I I Grek; 1972 Dec; 109(12):32-5. PubMed ID: 4664077
    [No Abstract]   [Full Text] [Related]  

  • 11. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y
    J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic modulation of portal pressure and its role in portal hypertension.
    Wheatley AM; Zhang X
    Digestion; 1998; 59(4):424-8. PubMed ID: 9693223
    [No Abstract]   [Full Text] [Related]  

  • 13. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
    Pinzani M; Gentilini P
    Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium].
    Sogni P; Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
    Lebrec D; Sicot C; Benhamou JP
    Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?
    Thabut D; Shah V
    J Hepatol; 2010 Nov; 53(5):976-80. PubMed ID: 20800926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does altered regulation of ecNOS in sinusoidal endothelial cells determine increased intrahepatic resistance leading to portal hypertension?
    Clemens MG
    Hepatology; 1998 Jun; 27(6):1745-7. PubMed ID: 9620353
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.